Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

Posted on Oct 12, 2017
EDEN PRAIRIE, Minn., Oct. 12, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today a 1-for-20 reverse split of its common stock, effective at 5:00 pm Eastern time today.  Beginning tomorrow, October 13, 2017, the Company's common stock will trade on The Nasdaq Capital Market ...

Read More

Posted on Sep 28, 2017
EDEN PRAIRIE, Minn., Sept. 28, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it is initiating international distribution of its products by entering into a distribution agreement with APC Cardiovascular Ltd., a distributor based in the United Kingdom. APC Cardiova...

Read More

Posted on Sep 21, 2017
EDEN PRAIRIE, Minn., Sept. 21, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, CEO, will be a featured presenter at the Ladenburg Thalmann 2017 Healthcare Conference at the Sofitel Hotel in New York City on September 26, 2017 at 1:30pm eastern time. Intere...

Read More

Events & Presentations